When Albert Bourla took over as CEO of Pfizer in January 2019, he said he wanted the pharmaceutical giant to be a more focused, innovative, science-based company. Bourla now finds himself at the forefront of developing and testing a COVID-19 vaccine in partnership with Germany’s BioNTech. Underway with a late-stage clinical trial for its vaccine, if successful, Pfizer said they could supply up to 100 million doses of the vaccine by the end of 2020. Bourla will discuss the timeline for a safe and effective vaccine and the state of the health industry during these uncertain times. Join Washington Post senior writer Frances Stead Sellers on Thursday, Aug. 6 at 2:00 p.m. ET.
Washington Post Live is the newsroom’s live journalism platform, featuring interviews with top-level government officials, business leaders, cultural influencers and emerging voices on the most pressing issues driving the news cycle nationally and across the globe. From one-on-one, newsmaker interviews to in-depth multi-segment programs, Washington Post Live brings The Post’s newsroom to life on stage. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK
In This Story: COVID-19
Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.
Symptoms of coronavirus
The main symptoms of coronavirus are:
- a persistent new cough (non productive, dry)
- a high temperature (e.g. head feels warm to the touch)
- shortness of breath (if this is abnormal for the individual, or increased)
Latest News about Covid-19
Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.
5 Recent Items: COVID-19
In This Story: Germany
5 Recent Items: Germany
In This Story: Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.